HilleVax Inc. (HLVX) NASDAQ
$15.82 0.20 (1.25%)
Market Cap: $776.33M
As of 03/28/24 10:52 AM EDT. Market open.
HilleVax Inc. (HLVX)
NASDAQ
$15.82
0.20 (1.25%)
Market Cap: $776.33M
As of 03/28/24 10:52 AM EDT. Market open.
hillevax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. our initial program, hil-214, is a virus-like particle (vlp) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus ... read more
hillevax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. our initial program, hil-214, is a virus-like particle (vlp) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Kohli Aditya | Director | Mar 20, 2024 | Sale | $164221.00 | 6,000 | 985,326,000 | 807,776 | Mar 20, 2024, 06:27 PM |
Kohli Aditya | Director | Mar 19, 2024 | Sale | $17.42 | 6,000 | 104,492 | 813,776 | Mar 20, 2024, 06:27 PM |
Kohli Aditya | Director | Mar 18, 2024 | Sale | $17.66 | 6,000 | 105,937 | 819,776 | Mar 20, 2024, 06:27 PM |
Kohli Aditya | Director | Mar 08, 2024 | Sale | $18.66 | 6,000 | 111,959 | 825,776 | Mar 08, 2024, 06:38 PM |
Kohli Aditya | Director | Mar 07, 2024 | Sale | $18.37 | 6,000 | 110,213 | 831,776 | Mar 08, 2024, 06:38 PM |
Kohli Aditya | Director | Mar 06, 2024 | Sale | $18.95 | 6,000 | 113,701 | 837,776 | Mar 08, 2024, 06:38 PM |
Kohli Aditya | Director | Feb 22, 2024 | Sale | $15.05 | 6,000 | 90,312 | 843,776 | Feb 22, 2024, 05:20 PM |
Kohli Aditya | Director | Feb 21, 2024 | Sale | $14.92 | 6,000 | 89,495 | 849,776 | Feb 22, 2024, 05:20 PM |
Kohli Aditya | Director | Feb 20, 2024 | Sale | $14.88 | 6,000 | 89,272 | 855,776 | Feb 22, 2024, 05:20 PM |
Kohli Aditya | Director | Feb 12, 2024 | Sale | $15.32 | 6,000 | 91,921 | 861,776 | Feb 14, 2024, 04:22 PM |
Kohli Aditya | Director | Feb 08, 2024 | Sale | $14.93 | 8,866 | 132,383 | 812,878 | Feb 12, 2024, 08:06 PM |
Maltbie Shane | Chief Financial Officer | Feb 08, 2024 | Sale | $14.93 | 3,576 | 53,395 | 40,656 | Feb 12, 2024, 07:51 PM |
HERSHBERG ROBERT | See Remarks | Feb 08, 2024 | Sale | $14.93 | 11,597 | 173,161 | 953,831 | Feb 12, 2024, 07:47 PM |
Borkowski Astrid | Chief Medical Officer | Feb 08, 2024 | Sale | $14.93 | 3,933 | 58,726 | 161,260 | Feb 12, 2024, 07:35 PM |
Borkowski Astrid | Chief Medical Officer | Dec 15, 2023 | Sale | $15.50 | 10,000 | 155,000 | 165,193 | Dec 18, 2023, 05:34 PM |
Borkowski Astrid | Chief Medical Officer | Dec 01, 2023 | Sale | $14.20 | 10,000 | 142,000 | 185,193 | Dec 05, 2023, 04:52 PM |
Borkowski Astrid | Chief Medical Officer | Dec 04, 2023 | Sale | $14.50 | 10,000 | 145,000 | 175,193 | Dec 05, 2023, 04:52 PM |
Borkowski Astrid | Chief Medical Officer | Nov 17, 2023 | Sale | $14.00 | 10,000 | 140,000 | 195,193 | Nov 20, 2023, 04:53 PM |
Borkowski Astrid | Chief Medical Officer | Nov 08, 2023 | Sale | $13.00 | 5,000 | 65,000 | 205,193 | Nov 13, 2023, 05:25 PM |
Borkowski Astrid | Chief Medical Officer | Jun 21, 2023 | Option Exercise | $16.11 | 10,000 | 161,100 | 210,193 | Jun 23, 2023, 10:09 AM |
Frazier Life Sciences X, L.P. | 10% Owner | May 03, 2022 | Option Exercise | $13.60 | 2,736,234 | 37,212,783 | 6,770,631 | May 03, 2022, 04:23 PM |
Frazier Life Sciences X, L.P. | 10% Owner | May 03, 2022 | Buy | $17.00 | 1,764,706 | 30,000,002 | 8,535,337 | May 03, 2022, 04:23 PM |
Owner | Relationship | Date | Value($) |
Kohli Aditya | Director | 03/20/2024 | 985,326,000 |
Kohli Aditya | Director | 03/19/2024 | 104,492 |
Kohli Aditya | Director | 03/18/2024 | 105,937 |
Kohli Aditya | Director | 03/08/2024 | 111,959 |
Kohli Aditya | Director | 03/07/2024 | 110,213 |
Kohli Aditya | Director | 03/06/2024 | 113,701 |
Kohli Aditya | Director | 02/22/2024 | 90,312 |
Kohli Aditya | Director | 02/21/2024 | 89,495 |
Kohli Aditya | Director | 02/20/2024 | 89,272 |
Kohli Aditya | Director | 02/12/2024 | 91,921 |
Kohli Aditya | Director | 02/08/2024 | 132,383 |
Maltbie Shane | Chief Financial Officer | 02/08/2024 | 53,395 |
HERSHBERG ROBERT | See Remarks | 02/08/2024 | 173,161 |
Borkowski Astrid | Chief Medical Officer | 02/08/2024 | 58,726 |
Borkowski Astrid | Chief Medical Officer | 12/15/2023 | 155,000 |
Borkowski Astrid | Chief Medical Officer | 12/01/2023 | 142,000 |
Borkowski Astrid | Chief Medical Officer | 12/04/2023 | 145,000 |
Borkowski Astrid | Chief Medical Officer | 11/17/2023 | 140,000 |
Borkowski Astrid | Chief Medical Officer | 11/08/2023 | 65,000 |
Borkowski Astrid | Chief Medical Officer | 06/21/2023 | 161,100 |
Frazier Life Sciences X, L.P. | 10% Owner | 05/03/2022 | 37,212,783 |
Frazier Life Sciences X, L.P. | 10% Owner | 05/03/2022 | 30,000,002 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,004,231 | 1.19% | No change | Other |
BLACKROCK INC. | 1,775,937 | 0.00073% | 37.93% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 591,145 | 0.00099% | 41.32% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 198,439 | 0.00659% | 12.42% | Other |
UBS OCONNOR LLC | 61,059 | 0.07% | -46.66% | Value |
ALPS ADVISORS INC | 28,914 | 0.00323% | Exited | Other |
TUDOR INVESTMENT CORP ET AL | 17,724 | 0.00229% | No change | Event Driven, Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View